Author: Claudia Patricia Moreno Alzate

July 4, 2024 All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, July 4, 2024 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCPK: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis

July 17,2024 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All amounts expressed in Canadian dollars unless otherwise noted TORONTO, Canada and RIONEGRO, Colombia (July 17, 2024) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC: PCLOF), the

May 7, 2024 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All amounts expressed in Canadian dollars unless otherwise noted TORONTO, Canada and RIONEGRO, Colombia (May 7, 2024) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC:

April 10, 2024 The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, will

March 26, 2024 • The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil – the State of São Paulo is the largest state in the country. • Ease Labs to supply up to 1.871

March 1, 2024 TORONTO, Canada and RIONEGRO, Colombia (March 1, 2024) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today commented

October 6, 2023 PharmaCielo Raises $3.3 Million under Previously Announced Non-Brokered Private Placement Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000. The Company also announced that it has agreed to issue shares and debt in settlement of

August 29, 2023 PharmaCielo Announces Q2 2023 Financial Results All figures in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, August 29, 2023 – PharmaCielo Ltd. (“PharmaCielo” or the “Company“) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer